PROMOTING ACCESS TO AFRICAN RESEARCH

Malawi Medical Journal

Log in or Register to get access to full text downloads.

Remember me or Register



Cotrimoxazole for childhood febrile illness in Malaria-endemic regions

PB Bloland, SC Redd, PN Kazembe, R Tembenu, JJ Wirima, CC Campbell

Abstract


The efficacy of co-trimoxozole for the treatment of Plasmodium falciparum parasitaemia in children younger than 5 years of age was evaluated in Malawi. 46 children with P. falciparum parasitaemia, 37% of whom also met clinical criteria for a diagnosis of acute lower respiratory tract infection, were treated with 20 mglkg co-trimoxazole twice daily for five days. Parasitaemia (mean clearance time 2.7 days) and symptoms were rapidly abolished and improvement was maintained during follow-up for 14 days. Co-trimoxazole may be an effective single treatment for febrile illness in young children in areas where malaria is endemic, resources are few, and diagnosis must rely on clinical findings alone.




AJOL African Journals Online